The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISHL HL Update 2021 | Elderly patients are an unmet need in Hodgkin lymphoma
Jonathan Friedberg
• 11 Mar 2021
Jonathan Friedberg, MD, University of Rochester, Rochester, NY, discusses the current standards of care of elderly patients with Hodgkin lymphoma and the importance of understanding outcomes of patients in this population, who are often excluded from clinical trials. This interview took place at the Update on Hodgkin Lymphoma 2021, a Virtual ISHL event.
